The search for effective tinnitus treatments continues to advance, bringing hope through a new wave of innovative approaches. Some therapies, like the Lenire and Levo devices, are available in clinics in the United States, while others remain in earlier stages of research. Below, ATA highlights some of the more promising emerging therapies in clinical settings or under investigation.

It’s important to note that while these treatments offer encouraging potential, most are still being investigated to determine exactly who they help, how they work, and what risks they may pose. This is especially true for treatments involving experimental therapies involving novel drugs or invasive procedures.

ATA supports ongoing innovation in tinnitus care but does not endorse any specific treatment due to the heterogeneous nature of tinnitus. Patients are strongly encouraged to consult with qualified hearing healthcare professionals, as well as the physicians managing their other health conditions, to determine the most appropriate treatment options, taking into consideration overall health, tinnitus severity and its impact on daily life.

Bimodal Neuromodulation

Bimodal neuromodulation is one of the most promising and well-studied emerging therapies for tinnitus. It works by combining sound stimulation (typically tones delivered via headphones) with mild electrical pulses to another part of the body. This pairing is designed to retrain the brain’s auditory and somatosensory pathways, reducing tinnitus perception and associated distress over time.  

The Lenire device, developed by Neuromod Devices, is currently the most widely used product and received FDA De Novo approval in 2023. While the device does not eliminate tinnitus, clinical trials and real-world data have shown that it can significantly reduce tinnitus symptoms, particularly under the supervision of skilled tinnitus healthcare professionals. The treatment is noninvasive, and side effects are generally mild, most commonly a tingling sensation on the tongue, where the device delivers gentle electrical stimulation via its tongue-tip interface. 

Vagus Nerve Stimulation (VNS) Paired with Sound Therapy

VNS is an emerging tinnitus therapy that involves  playing specific tones while stimulating the vagus nerve, a major nerve that interfaces with the brain and influences mood, attention, and inflammation. The idea is to enhance neuroplasticity and retrain how the brain interprets tinnitus. While VNS has been approved for epilepsy and depression, typically via implanted devices, researchers are exploring both implanted and noninvasive versions for tinnitus. Early studies suggest that this paired stimulation may help reduce tinnitus symptoms over time. Risks vary depending on the method of stimulation; implanted devices involve surgery and carry standard surgical risks, whereas noninvasive VNS approaches, such as stimulation through the ear or neck, are much safer but still experimental.

Cochlear Implant (CI)

CIs are a well-established treatment for deaf individuals or those with severe hearing loss, and they are also emerging as a therapeutic option for certain individuals with bothersome tinnitus. For eligible candidates, restoring auditory input via a CI can significantly reduce the perception of tinnitus, sometimes even eliminating it. This effect is believed to occur because the electrical stimulation provided by the implant helps suppress the brain’s tinnitus-related hyperactivity, which often arises in response to auditory deprivation. Clinical studies have shown that many CI recipients report a reduction in tinnitus severity post-implantation, especially when the device is turned on. Importantly, cochlear implantation is a surgical procedure with associated risks, including infection, device failure, or changes in taste and balance, though serious complications are relatively rare. Successful outcomes also depend on the patient’s active participation in post-implantation auditory rehabilitation to maximize both hearing and tinnitus management benefits.

Notched sound therapy device designed for use during sleep

The Levo System is a sound-based therapy for tinnitus that uses customized, barely audible tones, called “notched” sound therapy, designed to match an individual’s unique tinnitus profile. Worn overnight using earbuds, the FDA-cleared system aims to promote brain neuroplasticity and desensitization by subtly stimulating the auditory system while a person sleeps. Several studies have explored the Levo System’s clinical impact, with some reporting reductions in tinnitus severity and improved quality of life. However, larger-scale and longer-term studies are needed to fully validate its effectiveness. 

Transcranial Direct Current Stimulation (tDCS)

tDCS is a noninvasive neuromodulation technique that delivers low-intensity electrical currents to specific brain regions via scalp electrodes. tDCS aims to modulate neural activity in areas like the auditory cortex and prefrontal cortex, which are implicated in tinnitus perception and associated distress. While research findings are promising, the overall evidence for tDCS in tinnitus treatment remains mixed, with some studies reporting transient benefits and others showing no significant effects. Variability in stimulation parameters, electrode placement, and patient characteristics contribute to these inconsistent outcomes. Further large-scale, randomized controlled trials are necessary to establish standardized protocols and confirm the long-term efficacy and safety of tDCS for tinnitus management.

Transcranial Magnetic Stimulation (TMS)

TMS is a noninvasive brain stimulation technique that uses focused magnetic pulses to modulate neural activity in areas associated with tinnitus, such as the auditory cortex and limbic system. TMS is FDA-approved for treating major depression and continues to be explored as a treatment for tinnitus by reducing hyperactivity in auditory brain regions. Some individuals report a temporary or lasting reduction in tinnitus loudness or distress following treatment. However, results can vary significantly between individuals, and repeated sessions are often required to sustain benefits. Side effects are usually mild and may include scalp discomfort or headaches, though rare risks such as seizures exist. TMS holds promise, but it’s not yet considered a first-line treatment due to variability in outcomes and the need for more consistent research findings.

Repetitive Transcranial Magnetic Stimulation (rTMS)

rTMS is a form of noninvasive brain stimulation that continues to be investigated as a potential treatment for tinnitus. It works by delivering repeated magnetic pulses to targeted areas of the brain, typically the auditory cortex or regions involved in tinnitus perception. The goal of rTMS is to reduce abnormal neural activity or hyperactivity in these regions, which are thought to contribute to tinnitus. Research findings have been mixed, with some studies reporting temporary reductions in tinnitus loudness or distress, while others finding limited or no benefit. rTMS is generally well tolerated, with mild side effects such as scalp discomfort or headaches.

Transcutaneous Electrical Nerve Stimulation (TENS)

TENS is an emerging, noninvasive therapy being explored for tinnitus relief. It works by delivering mild electrical impulses through electrodes placed on the skin, often near the head or neck, to stimulate specific nerves. The goal is to modulate neural activity involved in tinnitus perception, particularly by targeting somatosensory pathways that interact with the auditory system. Preliminary research suggests that it may be beneficial for some individuals, especially those whose tinnitus is influenced by jaw or neck movements, a sign that somatosensory input could be playing a role. Some small studies have shown that TENS applied to areas like the cervical spine or trigeminal nerve can reduce tinnitus loudness or annoyance in some patients, though results have varied depending on stimulation site, frequency, and duration. Larger, well-controlled clinical trials are needed to confirm its effectiveness, identify which subgroups of patients may benefit, and establish optimal treatment protocols.

Experimental Therapies

Brain Implants

Brain implants, such as those being developed by companies like Neuralink, represent one of the most futuristic and experimental approaches to treating neurological disorders, including tinnitus potentially. These devices aim to establish a direct interface between the brain and external technologies known as brain-computer interfaces, or BCIs. In theory, such implants could be used to monitor and modulate abnormal neural activity associated with tinnitus in real time, effectively “quieting” the brain circuits responsible for tinnitus. While no brain implant has yet been approved or widely tested specifically for tinnitus, early animal studies and preliminary human trials targeting other neurological conditions, such as paralysis, epilepsy, and depression, are laying the groundwork for potential applications in tinnitus care. The concept is highly speculative at this stage and raises numerous safety, ethical, and technological questions. Implanting electrodes into the brain carries significant surgical risks, and long-term impacts are not yet well understood.

Deep Brain Stimulation (DBS)

DBS is a highly experimental and invasive treatment being studied for the most severe, intractable cases of tinnitus. DBS involves surgically implanting electrodes into specific areas of the brain, such as the thalamus or auditory cortex, to modulate abnormal neural activity associated with tinnitus. This approach builds on its success treating movement disorders like Parkinson’s disease and some forms of treatment-resistant depression. While preliminary results in small studies or case reports suggest that DBS might reduce tinnitus symptoms in select patients, it carries significant surgical and neurological risks.

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is an emerging area of interest in tinnitus care, particularly for individuals whose tinnitus is deeply intertwined with distress, anxiety, depression, or trauma. Compounds such as psilocybin and MDMA (commonly known as ecstasy) are being studied for their capacity to promote neural plasticity, emotional processing, and the reorganization of entrenched thought patterns. Early anecdotal reports and small pilot studies suggest that psychedelics may help some individuals. These treatments are currently administered in controlled clinical settings, with trained therapists guiding patients through preparation, the dosing session, and integration afterward. While the therapeutic potential seems to be promising, psychedelic therapy carries risks, particularly for those with a personal or family history of psychosis or bipolar disorder, and it remains illegal or experimental in many jurisdictions. That said, success in adjacent fields, such as PTSD, treatment-resistant depression, and addiction, has drawn significant interest to its potential application in chronic tinnitus distress.